Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 7 (2010), Issue 8 (August)

1. The use of patient-reported outcome measures and patient satisfaction ratings to assess outcome in hemiarthroplasty of the shoulder.
   J Bone Joint Surg Br, 92(8): 1107-11. [Abstract] [Full-text]
2. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase I.
   Ann Rheum Dis, 69(9): 1589-95. [Abstract] [Full-text]
3. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
   Ann Rheum Dis, 69(9): 1580-8. [Abstract] [Full-text]
4. Ability of ultrasound imaging to detect erosions in a bone phantom model.
   Ann Rheum Dis, 69(9): 1618-22. [Abstract] [Full-text]
5. Assessment of hand bone loss in rheumatoid arthritis by high-resolution peripheral quantitative CT.
   Ann Rheum Dis, 69(9): 1671-6. [Abstract] [Full-text]
6. Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis.
   Ann Rheum Dis, 69(9): 1623-8. [Abstract] [Full-text]
7. Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice.
   Ann Rheum Dis, 69(9): 1717-23. [Abstract] [Full-text]
8. Increased prevalence of diastolic dysfunction in rheumatoid arthritis.
   Ann Rheum Dis, 69(9): 1665-70. [Abstract] [Full-text]
9. Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)).
   Ann Rheum Dis, 69(9): 1629-35. [Abstract] [Full-text]
10. IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy.
    Ann Rheum Dis, 69(9): 1697-703. [Abstract] [Full-text]
11. Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples.
    Ann Rheum Dis, 69(9): 1711-6. [Abstract] [Full-text]
12. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis.
    Ann Rheum Dis, 69(9): 1612-7. [Abstract] [Full-text]
13. Genetic variants in the prediction of rheumatoid arthritis.
    Ann Rheum Dis, 69(9): 1694-6. [Abstract] [Full-text]
14. Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?
    Ann Rheum Dis, 69(9): 1636-42. [Abstract] [Full-text]
15. Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial.
    Ann Rheum Dis, 69(9): 1655-9. [Abstract] [Full-text]
16. Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort.
    Ann Rheum Dis, 69(9): 1683-6. [Abstract] [Full-text]
17. Demyelinating events in rheumatoid arthritis after drug exposures.
    Ann Rheum Dis, 69(9): 1691-3. [Abstract] [Full-text]
18. Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.
    Arthritis Rheum, 62(8): 2239-48. [Abstract] [Full-text]
19. Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease.
    Arthritis Rheum, 62(8): 2530-5. [Abstract] [Full-text]
20. Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration.
    Arthritis Rheum, 62(8): 2517-24. [Abstract] [Full-text]
21. SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
    Arthritis Rheum, 62(8): 2249-61. [Abstract] [Full-text]
22. Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis.
    Arthritis Rheum, 62(8): 2510-6. [Abstract] [Full-text]
23. Liposome-bound APO2L/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritis.
    Arthritis Rheum, 62(8): 2272-82. [Abstract] [Full-text]
24. Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis.
    Arthritis Rheum, 62(8): 2294-302. [Abstract] [Full-text]
25. Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: results of a randomized, double-blind, placebo-controlled, phase I/II study.
    Arthritis Rheum, 62(8): 2227-38. [Abstract] [Full-text]
26. Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis.
    Arthritis Rheum, 62(8): 2219-26. [Abstract] [Full-text]
27. Gene expression profile in the salivary glands of primary Sjögren's syndrome patients before and after treatment with rituximab.
    Arthritis Rheum, 62(8): 2262-71. [Abstract] [Full-text]
28. Quantification of the familial contribution to juvenile idiopathic arthritis.
    Arthritis Rheum, 62(8): 2525-9. [Abstract] [Full-text]
29. Rheumatoid arthritis of the hand: monitoring with a simplified MR imaging scoring method--preliminary assessment.
    Radiology, 256(3): 863-9. [Abstract] [Full-text]
30. Defective feedback regulation of NF-kappaB underlies Sjogren's syndrome in mice with mutated kappaB enhancers of the IkappaBalpha promoter.
    Proc Natl Acad Sci U S A, 107(34): 15193-8. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.